Predicting graft rejection

Details for Australian Patent Application No. 2004213839 (hide)

Owner Children's Medical Center Corporation Beth Israel Deaconess Medical Center, Inc.

Inventors Schachter, Asher; Strom, Terry B.; Libermann, Towia

Agent Davies Collison Cave

Pub. Number AU-B-2004213839

PCT Pub. Number WO2004/074815

Priority 60/447,540 14.02.03 US

Filing date 17 February 2004

Wipo publication date 2 September 2004

Acceptance publication date 12 August 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/074815 Priority application(s): WO2004/074815

21 September 2006 Change of Name(s) of Applicant(s), Section 104

  Beth Israel Deaconess Medical Center, Inc. The name of the applicant has been changed to Children's Medical Center Corporation; Beth Israel Deaconess Medical Center, Inc.

12 August 2010 Application Accepted

  Published as AU-B-2004213839

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213840-Filter containing a metal phthalocyanine and a polycationic polymer

2004213836-Compositions and methods for multiplex analysis of polynucleotides